HLA Typing for Transplant companies

Companies Dominating the HLA Typing for Transplant Landscape

There is an intensifying competition between the companies involved in the HLA typing for transplant market, with numerous strategies implemented to strengthen their global ecosystem. The market landscape is mainly dominated by key players in the U.S. and Europe, with a maximum revenue share of 78%, leveraging NGS automation and AI-based technologies. Besides, countries such as Thermo Fisher and Illumina are leading the market with high-precision sequencing. Hence, these constant efforts from major firms are dramatically influencing industry expansion. Here is a list of key players operating in the global market:

Company Name	Country	Market Share
Thermo Fisher Scientific	USA	24%
Illumina	USA	20%
QIAGEN	Germany	14%
Bio-Rad Laboratories	USA	10%
Roche Diagnostics	Switzerland	9%
Immucor (Werfen)	Spain	xx%
Becton Dickinson (BD)	USA	xx%
Luminex (DiaSorin)	Italy	xx%
Takara Bio	Japan	xx%
CareDx	USA	xx%
Omixon	Hungary	xx%
GenDx	Netherlands	xx%
Abbott Laboratories	USA	xx%
Sysmex	Japan	xx%
SeCore (Life Technologies)	USA	xx%
Histogenetics	USA	xx%
Cytologics	South Korea	xx%
TBG Diagnostics	Australia	xx%
XCyton Diagnostics	India	xx%
Inno-Train Diagnostics	Malaysia	xx%

Below are the areas covered for each company under the top 15 global manufacturers:

• Company Overview 
• Business Strategy 
• Key Product Offerings 
• Financial Performance 
• Key Performance Indicators 
• Risk Analysis 
• Recent Development 
• Regional Presence 
• SWOT Analysis